| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |